「GATA6とCK5の免疫組織化学的発現表現型が術前化学療法後切除膵癌の予後を層別化する」の関連論文
-
膠芽腫におけるPIK3CA遺伝子変異の臨床的意義についての考察
-
癌関連線維芽細胞はWnt5aを介して大腸癌の進展を促進する
-
M2マクロファージの上皮内蓄積は腫瘍性食道扁平上皮と強く相関する
-
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
-
Barrett食道癌周囲のBarrett粘膜におけるGlucocorticoid receptor (GR) 発現と粘膜固有層リンパ球浸潤に関する検討
-
可溶性ALK1発現型HSV-1のヒト腎細胞癌における治療効果の検討
-
17型コラーゲンは複数のシグナル伝達経路を介して膵癌の腫瘍形成を制御する
-
The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness
-
Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer
-
Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma
-
アルドステロン産生腺腫におけるコレステロール代謝と形態学的特徴/genotypesとの相関
-
Risk Factors for Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer
-
4NQO発癌モデルマウスを用いた舌癌発生過程における血管の改変
-
Matrix remodeling-associated protein 8 is a marker of a subset of cancer-associated fibroblasts in pancreatic cancer
-
イミキモド塗布による抗腫瘍効果のメカニズムの解明と、抗PD-1抗体との併用効果の検討
-
肝芽腫におけるDNA メチル化解析に基づく新規リスク層別化モデルの検討
-
Evaluation of Time to Failure of Strategy as an Alternative Surrogate Endpoint in Lung Cancer Patients with EGFR Mutations.
-
Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion
-
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
-
Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer
-
大腸癌におけるARID1A遺伝子変異の及ぼす影響および間質細胞のPD-L1発現との関連
-
全腫瘍体積は切除可能大腸癌肝転移における最も強い予後因子である
-
Clinical significance of lymphatic invasion in the esophageal region in patients with adenocarcinoma of the esophagogastric junction
-
移植後拒絶反応におけるOGG1の役割
-
食道扁平上皮癌におけるsignal regulatory protein alpha(SIRPα)発現の臨床的意義
-
Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients
-
Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency
-
サイトカインコーディングとマイクロ粒子センサアレイによるがんの可視化
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
がん免疫研究におけるマイクロサテライト不安定性大腸がん患者由来の異種移植モデル
-
The Value of Additional Conventional Transbronchial Biopsy in the Negative Results of Rapid On-site Evaluation During Endobronchial Ultrasound With Guide Sheath to Diagnose Small Peripheral Lung Cancer
-
鶏卵漿尿膜培養が、肺腺癌での血管新生におけるTIPARP (2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible poly (ADP-ribose) polymerase) の役割を解明した。
-
Prognostic Impact of Sarcopenia in Patients With Biliary Tract Cancer Undergoing Chemotherapy
-
小型肺腺癌における画像的浸潤度と腫瘍浸潤リンパ球の関連
-
Pathological studies on canine cutaneous epithelial tumors
-
切除不能初発肝内胆管癌に対する陽子線治療の成績の解析
-
Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method
-
Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis
-
マクロファージと癌細胞との相互作用により発現誘導されるIL-7Rの食道扁平上皮癌の進展における役割
-
The roles of adipose-tissue and malignant ascites in the development of peritoneal metastasis and the progression of ovarian cancer
-
BEX2は肝細胞がんにおける予後不良因子でありがん幹細胞形質の維持に必要である
-
AFP産生胃癌の治療標的探索と腫瘍免疫回避機構
-
胃癌深達度予測の為のAIシステムの開発並びに粘膜下層浸潤に着目した網羅的遺伝子発現解析による検討
-
大腸癌におけるバンド3異所性発現は赤血球膜結合IgGの増加を誘発し、免疫関連貧血の原因となる可能性がある
-
CARD9の肺腺がんの新しい予後因子としての可能性
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Visualization of lower extremity lymphedema in the same cohort using 99mTc-human serum albumin and 99mTc-phytate lymphoscintigraphy with SPECT-CT
-
Higher FVIII:C measured by chromogenic substrate assay than by one-stage assay is associated with silent hemophilic arthropathy
-
Analysis of microRNA in Bile Cytological Samples is Useful for Detection and Diagnosis of Extrahepatic Cholangiocarcinoma
-
Analysis of microRNA in Bile Cytological Samples is Useful for Detection and Diagnosis of Extrahepatic Cholangiocarcinoma